Report Overview:
Lactulose oral solution is a prescription medication primarily used to treat constipation by increasing water content in the colon, thereby softening stool and facilitating bowel movements. Additionally, it is widely prescribed for hepatic encephalopathy, a severe liver-related condition that leads to toxin buildup in the bloodstream. The medical lactulose oral solution market encompasses the production, distribution, and sale of lactulose-based treatments globally.
Market Value:
The global Medical Lactulose Oral Solution market was valued at USD 248 million in 2024 and is projected to grow to USD 326.42 million by 2032, reflecting a CAGR of 3.10% during the forecast period. CAGR of 3.10% (2025 – 2032)
By Types:
• Bagged Type
• Bottled Type
By Applications: Hospital Clinic
Key players include:
• Abbott
• Morinaga
• Fresenius Kabi
• Illovo
• Biofac
• Dandong Kangfu
• Including or Excluding key companies relevant to your analysis.
